VKTX


3 “Strong Buy” Stocks Under $10 That Are Poised to Take Off

It’s tempting to just buy into big names, and trust the herd wisdom to bring market returns. And that can work – there’s …

3 “Strong Buy” Biotech Stocks Trading Under $10

Wall Street is experiencing some major déjà vu. The tensions between the U.

William Blair Continues to Hold a Bullish View on Viking Therapeutics (VKTX) Stock Ahead of Upcoming Catalyst Events

Over the weekend, Viking Therapeutics (VKTX) presented additional encouraging results from a Phase II study of VK5211 in patients recovering from hip fracture …

Raymond James Beats the Drum for Viking Therapeutics (VKTX) Stock

Viking Therapeutics (VKTX) has currently five drugs in its development pipeline. Those drugs are targeting a variety of diseases including diabetes, metabolic diseases, …

Viking Therapeutics (VKTX) Stock Can Volt Even Higher, Says Analyst

Viking Therapeutics (VKTX) shares skyrocketed over 280% year-to-date thanks to positive mid-stage results for the drug maker’s experimental nonalcoholic steatohepatitis (NASH) candidate VK2809. …

This Top Analyst Reiterates Buy on Viking Therapeutics (VKTX) Stock; Here’s Why

Maxim’s top analyst Jason McCarthy is out today with a bullish note on shares of Viking Therapeutics (VKTX), after the drug maker announced positive new findings …

Viking Therapeutics (VKTX) Stock: Next Stop, $28?

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Viking Therapeutics …

This Analyst Just Doubled His Price Target on Viking Therapeutics (VKTX) Stock; Here’s Why

It’s a very rewarding trading day for investors in Viking Therapeutics (VKTX) with shares up nearly 80%, making the stock Wall Street’s bull …

Viking Therapeutics (VKTX) Gains Bigger Vote of Confidence from H.C. Wainwright

Following encouraging NASH data from VKTX’s biotech peer Madrigal, H.C.

Maxim Gets Even More Bullish on Viking Therapeutics (VKTX) on Back of Encouraging NASH Data Read-Out

Maxim’s Jason McCarthy now spotlights 67% in return potential for VKTX shares.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts